HIV patients developing primary CNS lymphoma lack EBV-specific CD4 + T cell function irrespective of absolute CD4+ T cell counts

PLoS Medicine

Volumn 4, Issue 3, 2007, Pages 556-561

  Gasser, Olivier ^a   Bihl, Florian K ^b   Wolbers, Marcel ^c   Loggi, Elisabetta ^b   Steffen, Ingrid ^d   Hirsch, Hans H ^d   Günthard, Huldrych F ^e   Walker, Bruce D ^b   Brander, Christian ^b   Battegay, Manuel ^a   Hess, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MALE; OPPORTUNISTIC INFECTION; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC DISEASE; CYTOLOGY; CYTOMEGALOVIRUS; METABOLISM; MIDDLE AGED; NOTE; VIROLOGY; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHRONIC DISEASE; CYTOMEGALOVIRUS; FEMALE; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; LYMPHOMA; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 33947629766     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040096     Document Type: Article

References (23)

1. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review. J Infect Dis 165: 352-363.
2. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
3. Gates AE, Kaplan LD (2002) AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16: 441-451.
4. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, et al. (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15: 2119-2127.
5. Osmond DH, Buchbinder S, Cheng A, Graves A, Vittinghoff E, et al. (2002) Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 287: 221-225.
6. Thirlwell C, Sarker D, Stebbing J, Bower M (2003) Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin Lymphoma 4: 86-92.
7. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, et al. (2005) Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425-432.
8. Bower M, Powles T, Nelson M, Mandalia S, Gazzard B, et al. (2006) Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. J Natl Cancer Inst 98: 1088-1091.
9. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H (2006) Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Incidence, presentation, treatment, and survival. Cancer 106: 128-135.
10. Battegay M, Nuesch R, Hirschel B, Kaufmann GR (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 6: 280-287.
11. Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, et al. (2005) Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection. J Infect Dis 192: 1513-1524.
12. Bihl FK, Loggi E, Chisholm JV 3rd, Hewitt HS, Henry LM, et al. (2005) Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion and "RecycleSpot". J Transl Med 3: 20.
13. + T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198: 903-911.
14. Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, et al. (1997) AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28: 367-374.
15. Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, et al. (2004) Human immunodeficiency virus-related primary central nervous system lymphoma: Factors influencing survival in 111 patients. Cancer 100: 2627-2636.
16. + T cell counts and recurrent retinitis. J Infect Dis 183: 1285-1289.
17. Cardine S, Kirch O, Labetoulle M, Offret H, Frau E (2001) Cytomegalovirus retinitis despite normal CD4 levels in an HIV patient. Report of a case. J Fr Ophtalmol 24: 971-974.
18. Thomson RM, Conrad D, Antoszewska H, Croxson MC, McCormack JG (1998) Cytomegalovirus retinitis, human immunodeficiency virus antibody positivity and normal T helper cell numbers. J Infect 37: 186-188.
19. Valdez H (2002) Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). AIDS Rev 4: 157-164.
20. Crothers K, Huang L (2003) Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy. HIV Med 4: 346-349.
21. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 75: 3740-3752.
22. +-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 77: 12088-12104.
23. + T lymphocytes. Nature 421: 852-856.